| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
APASL STC 2025, Istanbul
|
|
|
|
19 |
4 |
p. 994-1001
|
artikel
|
| 2 |
A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach
|
Zhang, Jie
|
|
|
19 |
4 |
p. 820-835
|
artikel
|
| 3 |
Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets
|
Zhu, Weixiong
|
|
|
19 |
4 |
p. 888-902
|
artikel
|
| 4 |
Commentary on “Predictive value of soluble PD-1 for HBsAg loss in HBeAg-negative chronic hepatitis B patients: a prospective study”
|
Cui, Shimeng
|
|
|
19 |
4 |
p. 976-977
|
artikel
|
| 5 |
Correction: Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation
|
Feng, Shu
|
|
|
19 |
4 |
p. 988-990
|
artikel
|
| 6 |
Correction: Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
|
Manzia, Tommaso Maria
|
|
|
19 |
4 |
p. 978-987
|
artikel
|
| 7 |
Correction: The interplay between lymphatic system and portal hypertension: a comprehensive review
|
Juneja, Pinky
|
|
|
19 |
4 |
p. 991-993
|
artikel
|
| 8 |
Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities
|
Lin, Anqi
|
|
|
19 |
4 |
p. 732-759
|
artikel
|
| 9 |
Developing a reliable prognostic nomogram for surgical hepatocellular carcinoma: unanswered questions
|
Huo, Teh-Ia
|
|
|
19 |
4 |
p. 970-971
|
artikel
|
| 10 |
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
|
Huang, Qizhen
|
|
|
19 |
4 |
p. 877-887
|
artikel
|
| 11 |
Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease
|
Arai, Jun
|
|
|
19 |
4 |
p. 836-845
|
artikel
|
| 12 |
Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies
|
Hui, Rex Wan-Hin
|
|
|
19 |
4 |
p. 704-719
|
artikel
|
| 13 |
Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma
|
Liu, Anran
|
|
|
19 |
4 |
p. 866-876
|
artikel
|
| 14 |
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis
|
Chen, Jing
|
|
|
19 |
4 |
p. 773-795
|
artikel
|
| 15 |
Impact of myosteatosis on outcomes after liver transplantation: a systematic review and meta-analysis
|
Yang, Lingpeng
|
|
|
19 |
4 |
p. 936-943
|
artikel
|
| 16 |
Impact of plasma exchange on bilirubin reduction and neurological impairment in infantile acute liver failure
|
Ide, Kentaro
|
|
|
19 |
4 |
p. 968-969
|
artikel
|
| 17 |
Lean-MAFLD: imperatives for updated evidence, mechanistic clarity, and methodological rigor
|
Yang, Longshan
|
|
|
19 |
4 |
p. 974-975
|
artikel
|
| 18 |
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China
|
Zhang, Xiu-Ping
|
|
|
19 |
4 |
p. 903-914
|
artikel
|
| 19 |
Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B
|
Ma, Hang-Yu
|
|
|
19 |
4 |
p. 796-808
|
artikel
|
| 20 |
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation
|
Chen, Jiafeng
|
|
|
19 |
4 |
p. 856-865
|
artikel
|
| 21 |
Predictive value of soluble PD-1 for HBsAg loss in HbeAg-negative patients with chronic hepatitis B: results from a prospective study
|
Guo, Huili
|
|
|
19 |
4 |
p. 809-819
|
artikel
|
| 22 |
Revisiting the safety profile of tenofovir alafenamide: methodological reflections on real-world data
|
El-Kassas, Mohamed
|
|
|
19 |
4 |
p. 972-973
|
artikel
|
| 23 |
Risk stratification for patients with primary biliary cholangitis: early versus advanced-stage or non-cirrhosis versus cirrhosis?
|
Ding, Dawei
|
|
|
19 |
4 |
p. 929-935
|
artikel
|
| 24 |
Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
|
Kim, Jae-Young
|
|
|
19 |
4 |
p. 959-967
|
artikel
|
| 25 |
Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B
|
Li, Jing
|
|
|
19 |
4 |
p. 760-772
|
artikel
|
| 26 |
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma
|
Rocco, Alba
|
|
|
19 |
4 |
p. 915-928
|
artikel
|
| 27 |
Targeted APT8(16–34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells
|
Yang, Xue
|
|
|
19 |
4 |
p. 944-958
|
artikel
|
| 28 |
Tenofovir alafenamide-related hyperlipidemia and cardiovascular risk
|
Jindal, Ankur
|
|
|
19 |
4 |
p. 701-703
|
artikel
|
| 29 |
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
|
Shimose, Shigeo
|
|
|
19 |
4 |
p. 846-855
|
artikel
|
| 30 |
The interplay between lymphatic system and portal hypertension: a comprehensive review
|
Juneja, Pinky
|
|
|
19 |
4 |
p. 720-731
|
artikel
|
Tijdschrift beschrijving